Rob ten Hoedt

Rob ten Hoedt is Executive Vice President & President EMEA & Canada, a role he has been in since 2009, with full responsibility for all sales and distribution of Medtronic products and therapies across these regions. He is a member of the Medtronic Executive Committee (ExCom).

Prior to leading the region, Rob ran the CardioVascular business for Europe & Central Asia as its Vice President.
Rob started his career in Medtronic in 1991 as Marketing Manager for the Neurological business in Western Europe, based in Brussels. In 1994, he went on to lead the start-up of Medtronic’s Gastro-Uro business in Europe, for which he subsequently held global responsibility.

Technological marvels in medical technology are arriving, and they will transform the entire healthcare chain It is not always easy to see a change occurring when it is happening right in front of you, so even those with long years of experience in healthcare might not recognise that the sector is currently undergoing a transformation like never before. The main driver for this change is Medtech innovation. Bold advances in a broad range of technologies like medical devices, in vitro diagnostics and imaging solutions can now solve health challenges that were previously considered insurmountable. The solutions and processes emerging today are ingenious in the way they can cure, fix and save us. But medtech is doing more than that. It is radically changing the way healthcare is delivered, the way professionals treat us, and the way we experience healthcare. Bench-to-bedside from cradle to grave While there have been many medical revolutions over the years, the current Medtech burst is different for a number reasons. It is partly related to the wider trend of technological advances and opportunities aimed at consumer-centric user-friendliness. The new generation of medtech innovation has an even greater focus on accessible benefits to doctors and nurses in combination with creating better and faster access to healthcare for patients around the globe. When combined with more widespread and faster Internet access, it opens up tremendous possibilities for the healthcare industry. This all is built on the foundation of the bench-to-bedside-to-bench development model, the process by which the results of research done in the laboratory is triggered by clearly articulated medical needs and are directly used to develop new treatments, in close collaboration with doctors, nurses and patients. In the past, medtech would focus on diagnostics and curative care (knee replacements, pacemakers), but today the focus is more on...